To understand why medical CE certification is inappropriate for CD bags, we must first examine what this certification actually entails. CE marking for medical devices in the European Union is governed by Regulation (EU) 2017/745, commonly known as the Medical Device Regulation (MDR), which replaced the previous Medical Device Directive (MDD 93/42/EEC) in May 2021 [1].
The MDR framework applies exclusively to products classified as medical devices, which are defined as instruments, apparatus, appliances, software, implants, reagents, materials, or other articles intended by the manufacturer to be used for human beings for specific medical purposes such as diagnosis, prevention, monitoring, treatment, or alleviation of disease. CD storage bags, cases, and sleeves clearly fall outside this definition.
The CE certification process for medical devices under MDR involves nine distinct stages [1]:
**1. Device Classification **(per Annex VIII) Medical devices are classified into four risk-based categories: Class I (low risk), Class IIa (medium risk), Class IIb (medium-high risk), and Class III (high risk). The classification determines the conformity assessment route and level of Notified Body involvement required.
2. Quality Management System Implementation: Manufacturers must implement a QMS compliant with ISO 13485 (Medical devices — Quality management systems). This is not optional - it's a mandatory prerequisite for CE marking under MDR for all device classes except some Class I devices.
**3. Technical Documentation Preparation **(Annex II/III) Manufacturers must compile comprehensive technical documentation including device description, design and manufacturing information, general safety and performance requirements, benefit-risk analysis, risk management, product verification and validation, pre-clinical and clinical data, and post-market surveillance plans.
**4. Notified Body Audit **(Stage 1 & Stage 2) For Class IIa, IIb, and III devices, a Notified Body (such as SGS with NB 1639 designation) must conduct a two-stage audit: Stage 1 reviews QMS documentation, Stage 2 is an on-site audit verifying implementation [1].
5. Clinical Evaluation: MDR requires significantly more rigorous clinical evidence compared to the previous MDD. Manufacturers must demonstrate clinical safety and performance through clinical investigations or equivalence to existing devices, with stricter requirements for implantable and Class III devices.
6. UDI System Implementation: The Unique Device Identification system requires manufacturers to assign unique identifiers to all medical devices, enabling traceability throughout the supply chain and post-market surveillance.
7. Declaration of Conformity & CE Marking: After successful completion of all requirements, manufacturers issue an EU Declaration of Conformity and affix the CE mark to their products.
**8. Post-Market Surveillance **(PMS) MDR mandates ongoing monitoring of device safety and performance after market entry, including periodic safety update reports (PSUR) for higher-risk devices.
9. Certification Cycle & Surveillance: CE certificates are valid for 5 years, with annual surveillance audits and unannounced audits conducted periodically. Recertification requires a complete reassessment.
Timeline Reality: The complete CE certification process for medical devices under MDR typically takes 18-36 months for Class IIa/IIb devices, and 24-48 months for Class III devices, with significant costs ranging from €50,000 to €500,000+ depending on device class and complexity
[1].
